+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Is the prognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients? A comparative analysis of clinical characteristics, prognostic features, and survival outcome



Is the prognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients? A comparative analysis of clinical characteristics, prognostic features, and survival outcome



Journal of Gastroenterology 43(11): 881-888



Hepatocellular carcinoma (HCC) is uncommon in young adults. This study examined the clinical characteristics and survival outcome of young HCC patients compared with those in older patients. Data were prospectively collected from 638 patients diagnosed with HCC over a 9-year period. Patients aged < or =40 years at diagnosis of HCC were defined as young HCC patients. Their clinical characteristics and survival was compared with those aged >40 years. The prevalence of young HCC was 8.6% (55/638). Young HCC patients had a significantly higher rate of hepatitis B-related disease (HBsAg positivity: 85.5% vs. 59.7%, P = 0.003), better Child-Pugh status (Child-Pugh class A: 69.1% vs. 43.9%, P = 0.002), and lower rates of cirrhosis (12.7% vs. 34.3%, P = 0.001) compared with the older group. They had more advanced disease at diagnosis, with higher alpha-fetoprotein levels (>12 000 microg/l: 45.4% vs. 30.5%, P = 0.026), a higher incidence of portal vein involvement (63.6% vs. 40%, P = 0.003), and a more advanced TNM stage (TNM IV: 83.6% vs. 66.4%, P = 0.018). More young patients were eligible for surgical resection (18.2% vs. 8.2%, P = 0.014). The overall survival between the two groups was similar, but when the patients were stratified for stage of disease, the median survival of young patients with early disease was superior to that of older patients (51.2 vs. 11.6 months, P = 0.025). HCC in young adults occurs mainly in hepatitis B carriers and is often diagnosed at an advanced stage. Their survival outcome is not different from that of older patients because the advanced disease at presentation offsets the advantages of better liver function and a higher resection rate. However, there is a distinct survival advantage for young patients diagnosed with early disease. These results support the importance of extending HCC surveillance to young hepatitis B carriers.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054000962

Download citation: RISBibTeXText

PMID: 19012042

DOI: 10.1007/s00535-008-2238-x


Related references

Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients. Liver International 26(7): 766-773, 2006

Hepatocellular carcinoma in extremely elderly patients: an analysis of clinical characteristics, prognosis and patient survival. World Journal of Gastroenterology 12(1): 48-53, 2006

Hepatocellular carcinoma in young adults: the clinical characteristics, prognosis, and findings of a patient survival analysis. Digestive Diseases and Sciences 52(4): 1103-1107, 2007

Hepatocellular carcinoma in the elderly: clinical characteristics, survival analysis, and prognostic indicators in a cohort of Spanish patients older than 75 years. Revista Espanola de Enfermedades Digestivas 100(10): 625-631, 2009

Clinical features and prognosis of hepatocellular carcinoma in young patients from a hepatitis B-endemic area. Journal of Gastroenterology and Hepatology 21(3): 588-594, 2006

Young colorectal carcinoma patients do not have a poorer prognosis: a comparative review of 2,426 cases. Techniques in Coloproctology 17(6): 653-661, 2014

The prognosis in cases of hepatocellular carcinoma after hepatectomy: young patients versus older patients. Korean Journal of Hepato-Biliary-Pancreatic Surgery 19(4): 154-160, 2015

Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival. Journal of Gastroenterology 43(2): 159-170, 2008

Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients. Cancer 64(8): 1700-1707, 1989

Clinicopathologic features and prognosis of young patients with hepatocellular carcinoma in a large German cohort. Journal of Clinical Gastroenterology 46(9): 775-778, 2013

Comparison of clinical characteristics of non-B non-C hepatocellular carcinoma and hepatitis virus-related hepatocellular carcinoma and prognosis in Uighur patients. Zhonghua Zhong Liu Za Zhi 37(7): 540-544, 2016

Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma. World Journal of Gastroenterology 13(3): 414-420, 2007

Hepatocellular carcinoma with portal vein tumor thrombosis: clinical characteristics, prognosis, and patient survival analysis. Digestive Diseases and Sciences 52(11): 3290-3295, 2007

Renal cell carcinoma in young patients is associated with poorer prognosis. Annals of the Academy of Medicine, Singapore 40(9): 401-406, 2012

Hepatocellular carcinoma in the elderly: clinical characteristics, treatment, survival analysis in Korean patients older than 70 years. Journal of Korean Medical Science 27(10): 1147-1154, 2013